CANCELLED_PROactive Solutions for Prolonging Resilience (PROSPR) Proposers' Day
ID: ARPA-H-SN-25-125Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)

Original Source

https://sam.gov/opp/567b975cfe214d70855dca4e524db248/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), has announced the cancellation of the Proposers' Day event for the PROactive Solutions for Prolonging Resilience (PROSPR) program, originally scheduled for January 24, 2025. This program aims to extend individuals' healthspan by 20 years and prevent age-related diseases, focusing on developing an Intrinsic Capacity (IC) score, repurposing FDA-approved drugs, and advancing innovative healthspan interventions. Although the Proposers' Day has been cancelled, the draft Innovative Solutions Opening (ISO) is anticipated in December 2024, with a final ISO expected in January 2025, and interested parties are encouraged to register and submit teaming profiles by January 21, 2025. For further inquiries, contact the PROSPR Team at PROSPR@arpa-h.gov.

    Point(s) of Contact
    The PROSPR Team
    PROSPR@arpa-h.gov
    Files
    Title
    Posted
    ARPA-H-SOL-25-125_Special Notice.pdf
    The Advanced Research Projects Agency for Health (ARPA-H) announces a Proposers’ Day event on January 24, 2025, regarding the PROactive Solutions for Prolonging Resilience (PROSPR) Program. This program aims to develop interventions that extend healthspan by 20 years by addressing age-related health decline and accelerating the research and development of therapeutics. The day will promote engagement within the research community, clarify program objectives, and encourage collaboration among potential project performers. The PROSPR program focuses on three main technical areas: developing an intrinsic capacity (IC) score for tracking health outcomes, repurposing FDA-approved drugs for healthspan extension, and advancing innovative preclinical interventions. The event will be hybrid, held in-person in Dallas, Texas, and virtually via Zoom, with a limited number of presentations and networking opportunities. Registration is required by January 21, 2025, and interested parties can submit "teaming profiles" to connect with potential collaborators. This event is informational and voluntary, with no obligation to submit proposals. The highlighting aspect is the removal of lengthy clinical trials, paving the way for efficient healthspan therapeutics development, and ultimately transforming geriatric medicine into a proactive model emphasizing preventative care.
    PROSPR Special Notice_REV 2_22 JAN.pdf
    The Advanced Research Projects Agency for Health (ARPA-H) is hosting a virtual Proposers’ Day event for the PROactive Solutions for Prolonging Resilience (PROSPR) program on January 24, 2025. This program seeks to extend Americans' healthspan by 20 years by addressing the underlying causes of health deterioration related to aging, aiming to prevent multiple age-related diseases simultaneously. Proposals focusing on three technical areas are encouraged: the development of a composite intrinsic capacity score for health prediction, repurposing of FDA-approved drugs for healthspan extension, and innovation in preclinical interventions to enhance healthspan. The Proposers’ Day will introduce attendees to program goals, clarify logistics, and promote collaboration among potential performers. Registration is required by January 21, 2025, and is open for both virtual and in-person attendance in Dallas, Texas. The event will feature presentations and opportunities for networking, including lightning talks for participants to discuss their capabilities and desired partnerships. Overall, this initiative underscores ARPA-H's commitment to advancing healthcare solutions focusing on proactive health management and preventive care for aging populations while transforming geriatric medicine into a more personalized model.
    PROSPR Special Notice_REV 3_23 JAN.pdf
    The Advanced Research Projects Agency for Health (ARPA-H) has issued a Special Notice for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at extending individuals' healthspan by 20 years and preventing age-related diseases. The Proposers’ Day event scheduled for January 24, 2025, has been cancelled, and the draft Innovative Solutions Opening (ISO) is expected in December 2024, with a final ISO in January 2025. The program emphasizes developing an Intrinsic Capacity (IC) score, repurposing FDA-approved drugs, and advancing innovative healthspan interventions. Attendees should register by January 21, 2025, and submit teaming profiles outlining their technical competencies and collaboration interests. The event will include presentations and opportunities for "lightning talks" to foster collaboration among potential performers. It is important to note that attendance is voluntary and does not obligate participants to submit proposals. The notice serves solely for informational purposes and does not solicit proposals at this time.
    Lifecycle
    Title
    Type
    ARPA-H PROactive Solutions for Prolonging Resilience (PROSPR) Proposers' Day
    Currently viewing
    Special Notice
    Similar Opportunities
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    Emerging Health Innovators (EHI) Initiative
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Emerging Health Innovators (EHI) Initiative, aimed at fostering innovative biomedical solutions from early-career researchers and community-based organizations. This initiative invites submissions under two tracks: Technology-Driven Innovation and Community-Centered Innovation, with a focus on addressing significant gaps in health innovation and community health management. Proposals may seek funding up to $350,000 annually for a duration of two years, with a potential extension for a third year, and must adhere to strict compliance guidelines regarding research security, intellectual property, and human and animal subject research. Interested parties should contact the EHI Initiative Team at EHI@ARPA-H.gov, with proposals due by February 5, 2025, following a Proposers' Day on January 8, 2025.
    Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
    Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
    ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual event titled RAPID Patients’ Day on February 25, 2025, aimed at introducing the RAPID Program focused on utilizing artificial intelligence (AI) and machine learning (ML) for precision diagnostics in rare diseases. This event will provide insights into the ARPA-H mission, program goals, and the role of Patient Experience (PX) Partners, encouraging participation from patient advocacy groups to foster engagement and collaboration. The RAPID Program seeks to alleviate the diagnostic challenges faced by rare disease patients by developing innovative diagnostic tools and integrating comprehensive data, with registration for the event opening on December 19, 2024, and closing on February 21, 2025. Interested participants can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.
    Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening. This initiative aims to develop innovative in silico human physiology modeling platforms that enhance drug safety assessments and reduce reliance on animal testing in preclinical studies, focusing on leveraging AI/ML for ADME-Tox simulations. The program is structured in two phases, with Phase I dedicated to developing predictive tools and Phase II aimed at integrating these tools into regulatory submissions for IND-enabling studies. Interested parties must submit a solution summary by November 25, 2024, and proposals by February 14, 2025, with all submissions made through the designated online platforms. For further inquiries, contact the CATALYST team via email at CATALYST@arpa-h.gov.
    Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) titled "Rare Disease AI/ML for Precision Integrated Diagnostics" (RAPID). This initiative aims to enhance the diagnostic processes for rare diseases by developing advanced diagnostic support tools and optimizing large-scale health data collection, particularly focusing on underdiagnosed populations. The RAPID program is critical for addressing the prolonged diagnostic odysseys faced by millions of rare disease patients, with a structured approach that includes aggregating existing health data, collecting novel patient data, and creating a Rare Disease Data Commons for analytical evaluation. Interested parties can direct inquiries to the RAPID Email Box at RAPID@ARPA-H.gov, and should note that the program will operate over a proposed 4.5-year span, with specific milestones and evaluation criteria to ensure effective project execution.
    ARPA-H ImagiNg Data EXchange (INDEX)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. The primary objective is to develop a sustainable platform that connects medical imaging data providers with researchers and developers, leveraging artificial intelligence and machine learning to address the shortage of qualified radiologists and improve healthcare outcomes. This initiative is critical for advancing algorithm development and clinical studies by creating a comprehensive repository of diverse imaging datasets, including cancer digital pathology and surgical videos. Interested parties must submit their Solution Summary by January 28, 2025, with the full proposal due by March 27, 2025. For further inquiries, contact the INDEX Team at INDEX@arpa-h.gov.
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Buyer not available
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting innovative research proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which is open until October 18, 2027. The initiative aims to address high-risk biomedical challenges related to public health emergencies, with specific Areas of Interest (AOIs) including drug repurposing, at-home diagnostics, and vaccine development. This program is crucial for enhancing the nation’s preparedness against emerging infectious diseases and other health threats, emphasizing the importance of innovative solutions in medical countermeasures. Interested parties must have active registration with SAM.gov and are encouraged to schedule pre-submission calls; key deadlines for abstract submissions vary by AOI, with multiple awards anticipated based on scientific merit and alignment with program goals.